Payne John Bernard's Form 4 filing
Zivo Bioscience, Inc. (ZIVO) · filed Jan 28, 2022
- Accession no.
- 0001654954-22-000864
- Filed
- Jan 28, 2022
- Trade date
- Jan 25-27, 2022
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $22.9K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Payne John BernardCIK 0001582392 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2022 | Common Stock | PPurchaseAcquired | +9,122 | $2.50 | +$22,805 | 9,298 | Direct | |
| Jan 27, 2022 | Common Stock | PPurchaseAcquired | +46 | $2.50 | +$115 | 9,344 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.